4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514438, 546329, 546334, 546337, 548202, 548204, 548205, 5483355, 5483751, 548561, 549 74, 549 75, 549 77, 549492, 549493, 540567, C07D 3320, C07D21338, A61K 3144, A61K 3138

Patent

active

052927601

ABSTRACT:
Novel 4,5-dihydro-4-heteroaryl-3H-1,3-benzodiazepines, intermediates, processes for the preparation thereof, and methods for treating depression, inhibiting convulsions and treating anxiety utilizing compounds and compositions thereof are disclosed.

REFERENCES:
P. K. Kadaba, Drugs of the Future, 15, pp. 1013-1024, 1990.
J. B. Uney et al., Scrip Reports Neurodegeneration and Neuroprotection, "Molecular and Cellular Events Accompanying Nerve Cell Death", pp. 35-40, 1990.
SCRIP Reports, Neurodegeneration and Neuroprotection, M. V. Sonfroniew et al., "Experimental Models of Neuronal Degeneration and Alzheimer's Disease", pp. 10-16 (1990).
D. M. Barnes on Science, 235, 632 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-153699

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.